INSIGHTS ON QUALITY ASSURANCE

  • For Greater Transparency And Efficiency
    7/21/2026

    Paper-heavy production can slow decisions and limit flexibility. See how IT/OT integration connects shop-floor and enterprise data to support real-time visibility and more resilient operations.

  • Best Practice Approaches To Operational Readiness
    12/11/2024

    Learn how to implement a focused operational readiness model that goes beyond traditional construction and startup schedules. Discover how this approach can reduce timelines and improve project success.

  • The Future Of QC Is Now
    5/5/2026

    Pharma Industry 4.0 is reaching microbiological quality control. See how automation and digital workflows are transforming manual QC processes, improving productivity, and reliability.

  • The Role Of CDMOs In Supporting Generic Drug Development
    7/15/2025

    Bringing complex generics to market requires deep expertise. Learn how a CDMO can help navigate regulatory, technical, and commercial challenges with end-to-end development and manufacturing support.

  • Vertex On Building Risk Into Manufacturing Network Strategy
    9/17/2026

    Supply disruptions are becoming harder to predict. Explore practical strategies for continuity planning, supplier risk management, and network design to build lasting resilience.

QUALITY ASSURANCE SOLUTIONS

  • As the time, costs and complexity of cleaning validation challenges grow, savvy life sciences companies are building a competitive advantage around smarter approaches to cleaning validation.

  • Bring together contamination control, modular flexibility, leak testing, ergonomic operation, and validation-ready automation to support safer workflows and dependable performance at scale.

  • Streamline your facility lifecycle with a unified validation framework designed to maximize process control, reduce downtime, and meet stringent sterility compliance. 

  • The pharmaceutical industry continues to bring breakthroughs in the field of new vaccines and drug delivery systems amidst the increased scrutiny of the regulators. The packaging acts as the primary sterile barrier in drug delivery systems that safeguard the drug product through its life cycle. The efficiency of the primary sterile barrier and the functional components are of utmost importance to patient safety.

  • Blue Mountain Regulatory Asset Manager (RAM) helps life sciences manufacturers standardize maintenance, calibration, and asset workflows across sites in one validated platform.